Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 24:10:170.
doi: 10.3389/fcimb.2020.00170. eCollection 2020.

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia

Affiliations

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia

Miaomiao Xu et al. Front Cell Infect Microbiol. .

Abstract

Background: The prevalence of different underlying cryptococcal diseases in human immunodeficiency virus (HIV)-infected patients screened positive for cryptococcal antigenemia and the association between cryptococcal diseases and serum cryptococcal antigen (CrAg) titers were understudied. Methods: HIV-infected patients with CD4 < 200 cells/ul, admitted to the second hospital of Nanjing, Nanjing, China, from January 2016 to September 2019, were retrospectively analyzed. Integrated into routine HIV care, all these patients were screened for cryptococcal antigenemia with CrAg lateral flow assay. Positive patients received extensive laboratory and radiological studies to evaluate underlying cryptococcal diseases. Results: A total of 872 HIV inpatients were screened for serum CrAg. The prevalence of cryptococcal antigenemia in the study population was 10.3% (95% CI, 8.3-12.3%), 87.6% of which with cryptococcal antigenemia had clinically cryptococcal diseases. The prevalence of cryptococcal meningitis (CM), cryptococcemia and pulmonary cryptococcosis (PC) in patients with cryptococcal antigenemia were 58.4% (95% CI, 48.0-68.9%), 50.7% (95% CI, 39.1-62.2%), and 68.5% (95% CI, 58.7-78.4%), respectively. The median (range) serum CrAg titers in severe cryptococcal diseases (CM or cryptococcemia), localized PC (without co-existing CM or cryptococcemia) and isolated cryptococcal antigenemia were 1:2560 (1:10-1:2560), 1:20 (1:2-1:320), and 1:5 (1:2-1:320), respectively. Serum CrAg titers ≥1:320 were independently associated with CM (adjusted OR 26.88; 95%CI, 8.36-86.42). Severe cryptococcal diseases were found in all patients with serum CrAg titers ≥1:640. None of the patients with serum CrAg titers ≤ 1:5 had CM. Conclusion: The prevalence of cryptococcal antigenemia was high in HIV inpatients, supporting routine CrAg screening. Clinical cryptococcal diseases, most commonly the PC, existed in the majority of the patients with cryptococcal antigenemia. Since serum CrAg titer is correlated with cryptococcal disease severity, it may possibly guide anti-fungal treatment.

Keywords: HIV; cryptococcal antigenemia; cryptococcal meningitis; lateral flow assay; pulmonary cryptococcosis.

PubMed Disclaimer

References

    1. Beyene T., Zewde A. G., Balcha A., Hirpo B., Yitbarik T., Gebissa T., et al. (2017). Inadequacy of high-dose fluconazole monotherapy among cerebrospinal fluid cryptococcal antigen (CrAg)–positive human immunodeficiency virus-infected persons in an ethiopian CrAg screening program. Clin. Infect. Dis. 65, 2126–2129. 10.1093/cid/cix613 - DOI - PMC - PubMed
    1. Chen J., Zhang R., Shen Y., Liu L., Qi T., Wang Z., et al. (2019). Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis. HIV Med. 20, 69–73. 10.1111/hiv.12679 - DOI - PubMed
    1. Ford N., Shubber Z., Jarvis J. N., Chiller T., Greene G., Migone C., et al. (2018). CD4 cell count threshold for cryptococcal antigen screening of HIV-infected individuals: a systematic review and meta-analysis. Clin. Infect. Dis. 66(Suppl_2), S152–S159. 10.1093/cid/cix1143 - DOI - PMC - PubMed
    1. French N., Gray K., Watera C., Nakiyingi J., Lugada E., Moore M., et al. (2002). Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 16, 1031–1038. 10.1097/00002030-200205030-00009 - DOI - PubMed
    1. Ganiem A. R., Indrati A. R., Wisaksana R., Meijerink H. A, van der Ven Alisjahbana B., et al. (2014). Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia. J. Int. AIDS Soc. 17:18821. 10.7448/IAS.17.1.18821 - DOI - PMC - PubMed

Publication types

Substances